Research > ETFs > ETF / ETP Commentary > 

Signs of AI Slowdown Could Be Evident in Nvidia, Palantir

The recent price weakness in Nvidia and Palantir could mean the proverbial air is coming out of the AI hype balloon. Nonetheless, traders have options if AI does experience a slowdown.Of course, it’s hard to see AI faltering given that more companies are integrating the technology in their operations and products. However, stocks like Nvidia could see investor interest wane, However, the company recently reported better-than-expected earnings.Muted Response?Given AI’s serendipitous rise over the last few years, especially Nvidia, it could be that the hype was already priced into the rally. If that’s the case, any future positive momentum from strong earnings could result in a muted response. ""This stock has been dead money since June 2023, and when stocks post ‘better than expected’ results and can’t rally, it tells you that all the good news has been priced in," said Mott Capital founder Michael Kramer. Opportunistic traders may sense that short-term price weakness is just that — only in the short term. As such, they may feel compelled to buy the dip. Traders looking for added exposure could consider the Direxion Daily NVDA Bull 2X Shares (NVDU B+). If price weakness persists, traders can also profit by taking the bearish position with the Direxion Daily NVDA Bear 1X Shares (NVDD A-). Alternatively, they can pair it with their bullish positions in Nvidia as a hedge against losses. Big data company Palantir has also been feeling the pinch as of late. That’s because its stock reached a high in mid-February, but has fallen over 30% since. The company relies on AI technology to help interpret data in its platforms. The precipitous loss in momentum might mean quick sell-offs could be a recurring theme. “Among the top retail-traded stocks, Palantir could be the most vulnerable to a loss of retail momentum. if I were to pick a single name that could be most at risk of an unwind, PLTR would be it,” said Vanda Research SVP Marco Iachini.2 Options to Trade PalantirDespite the recent weakness, Palantir’s stock is far from struggling. Shares are up over 12% for the year. And big data should continue to see growth in a tech-reliant world that’s hungry for information. That said, traders can lever up their exposure to Palantir with the Direxion Daily PLTR Bull 2X Shares (PLTU). A trader with 100 shares of Palantir doesn’t need to add another 100 to get double exposure. PLTU will automatically allow a trader to double up their position with one trade. On the other hand, if the stock price continues to trend lower, traders can take the bearish position with the Direxion Daily PLTR Bear 1X Shares (PLTD). Rather than using options to short the stock, PLTD will allow for this exposure in an ETF format. LIke NVDD, PLTD allows for flexibility in a down-trending market to give traders the ability to profit when short-term price weakness occurs.For more news, information, and analysis, visit the Leveraged & Inverse Channel.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.